Laxmi Organic Industries Limited

NSE:LXCHEM.NS

268.65 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 7,712.537,181.677,920.66,942.976,522.697,335.797,331.96,546.446,521.987,566.118,753.188,598.786,080.957,363.515,110.384,355.194,097.934,036.133,865.12
Cost of Revenue 4,947.785,872.636,320.554,812.34,617.014,778.624,880.174,389.74,492.074,569.216,552.925,517.374,695.064,774.173,671.452,693.672,840.142,896.592,740.61
Gross Profit 2,764.751,309.041,600.052,130.671,905.682,557.172,451.732,156.742,029.912,996.92,200.263,081.411,385.892,589.341,438.931,661.521,257.791,139.541,124.51
Gross Profit Ratio 0.3580.1820.2020.3070.2920.3490.3340.3290.3110.3960.2510.3580.2280.3520.2820.3820.3070.2820.291
Reseach & Development Expenses 00165.12000137.58000113.9800085.860000
General & Administrative Expenses 00985.10001,531.5000330.74000362.250000
Selling & Marketing Expenses 0020.3800021.5600010.0100013.460000
SG&A 1,010.09855.81,005.48663.47650.83346.611,553.061,319.541,449.32283.83340.75334.78284.94834.73375.71214.94188.79168.54197.08
Other Expenses 2,292.43119.76107.353.482.0639.5338.3832.4228.5621.17-101.7420.266.7842.74-28.1419.154.245.250
Operating Expenses 2,292.43855.81,005.481,883.361,791.851,993.42,075.121,796.711,913.522,124.991,481.392,028.721,189.751,245.41825.771,107.03938.61831.81,042.51
Operating Income 472.32453.24594.57300.71195.89563.77414.99392.45144.95871.91618.61,052.69196.141,343.93525.53573.64351.17307.7462.37
Operating Income Ratio 0.0610.0630.0750.0430.030.0770.0570.060.0220.1150.0710.1220.0320.1830.1030.1320.0860.0760.016
Total Other Income Expenses Net -9.8486.5885.29-5.2-20.61-6.4612.35-57.05-43.69-3.02-44.32-49.0855.9414.67-38.28-38.82-63.92-33-22.68
Income Before Tax 462.48539.82679.86295.51175.28557.31427.34335.4101.26868.89564.651,003.61252.081,358.6487.25534.82287.25274.7439.69
Income Before Tax Ratio 0.060.0750.0860.0430.0270.0760.0580.0510.0160.1150.0650.1170.0410.1850.0950.1230.070.0680.01
Income Tax Expense 181.61196.31236.8123.6268.15174.02184.6362.714.99220.11-10182.63106.41335.35123.6182.7145.9261.2362.08
Net Income 280.87343.51443.04271.89107.13383.29243.17272.2885.99648.63573.96820.83145.671,023.25363.34452.11241.33213.51100.4
Net Income Ratio 0.0360.0480.0560.0390.0160.0520.0330.0420.0130.0860.0660.0950.0240.1390.0710.1040.0590.0530.026
EPS 1.011.241.620.990.41.440.921.030.322.462.182.680.553.881.552.011.070.950.46
EPS Diluted 11.231.620.970.41.440.911.020.322.442.162.630.543.851.552.011.070.950.46
EBITDA 813.41711.96900.1576.01471.38812.9645.45580.36314.831,036.27708.781,206.78375.581,495.42641.69695.7438.54424.88177.85
EBITDA Ratio 0.1050.0990.1140.0830.0720.1110.0880.0890.0480.1370.0810.140.0620.2030.1260.160.1070.1050.046